Drawing for MYMATRIXX POWERPA

USPTO serial 97458989

MYMATRIXX POWERPA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ANDERSON, DANIELLE LYNN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MYMATRIXX POWERPA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Troy E. Larson

1601 CHESTNUT STREET, TL7TWO LIBERTY PLACEPHILADELPHIA, PA 19192

Goods and services

ClassDescriptionStatusFirst use
035Drug utilization review services and prescription drug formulary cost management services; pharmaceutical cost management services; strategic business analysis and business advice regarding pharmacy benefit management, pharmaceutical end-user behavior, healthcare use behavior; market study and analysis of healthcare, healthcare benefits, pharmacy benefits effecting health behavior change and choice at the patient level, and healthcare management services, namely, processing data and statistics for others for the purpose of developing cost management protocols for the treatment of pain and diseases; Healthcare and pharmaceutical cost management services utilizing medical information and analysis; Providing referrals in the field of workers' compensation utilizing medical information and analysisACTIVE—
036Pharmacy benefit management services in the field of workers' compensation; pharmacy benefit management consulting services in the field of workers' compensation; medical benefit management services in the field of workers' compensation; advisory services and consultancy regarding healthcare insurance benefits and pharmacy insurance benefits in the field of workers' compensation; provision of information and analysis in the fields of healthcare insurance benefits and pharmacy insurance benefits in the field of workers' compensation; insurance administration of pharmacy benefit plans; pharmacy benefit management services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, and providing a predictive model to determine patients' future prescription drug and healthcare habits, all to identify potential cost savings and for clinical benefits for injured workersACTIVE—
044Providing medical information utilizing medical analysis in the fields of healthcare and pharmaceuticals and workers compensation; providing information in the field of healthcare as provided to pharmacy benefit management services clients, consultants and brokers, to improve clinical outcomes for injured workersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 6, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 6, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 5, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 4, 2026EX5GSOU EXTENSION 5 GRANTED—
May 4, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 1, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 30, 2025EXT5SOU EXTENSION 5 FILED—
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 29, 2025EX4GSOU EXTENSION 4 GRANTED—
May 29, 2025EXT4SOU EXTENSION 4 FILED—
May 29, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 27, 2024EX3GSOU EXTENSION 3 GRANTED—
Nov 27, 2024EXT3SOU EXTENSION 3 FILED—
Nov 27, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 2, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 1, 2024EX2GSOU EXTENSION 2 GRANTED—
May 1, 2024EXT2SOU EXTENSION 2 FILED—
May 1, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 17, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 13, 2023EX1GSOU EXTENSION 1 GRANTED—
Oct 13, 2023EXT1SOU EXTENSION 1 FILED—
Oct 13, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 30, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 4, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 4, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 15, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 28, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 28, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Feb 28, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 28, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 28, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 22, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 22, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 22, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 26, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 26, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 26, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 19, 2022DOCKASSIGNED TO EXAMINER—
Jun 28, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 18, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance